RI
Regenxbio Inc
🇩🇪XFRA.RB0GermanyHealthcare
€6.80EURdown -0.65 (-8.72%)ClosedEnd of day4:50 AM
Price€6.80-0.65 (-8.72%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US75901B1070
- CUSIP
- Not reported
Company
- Employees
- 371
- Headquarters
- Rockville, United States
- Website
- https://www.regenxbio.com
- CEO
- Mr. Curran M. Simpson M.S.
Market
- Shares outstanding
- 66M
- Market cap
- €448.89M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €448.89M
- EPS LTM
- -$2.98calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $174.48M+12%up year on year
- Net income
- -$196.43M-11.88%down year on year
- Gross margin
- 54.22%-32.17%down year on year
- Free cash flow
- -$249.67M-175.25%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.